CCB
NBSE

Cutter & Co Brokerage’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History

Cutter & Co Brokerage’s Portfolio NBSE Stock Details NBSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-100
Closed -$74K – 279
2017
Q4 		$74K Buy
100
+3
+3% +$1.16K 0.03% 244
2017
Q3 		$28K Sell
97
-15
-13% -$4.1K 0.01% 259
2017
Q2 		$29K Hold
112
– – 0.01% 270
2017
Q1 		$37K Sell
112
-4
-3% -$1.85K 0.02% 257
2016
Q4 		$69K Buy
116
+1
+0.9% +$1.06K 0.03% 237
2016
Q3 		$130K Sell
115
-4
-3% -$4.32K 0.06% 215
2016
Q2 		$130K Hold
119
– – 0.06% 212
2016
Q1 		$153K Hold
119
– – 0.07% 209
2015
Q4 		$292K Sell
119
-14
-11% -$21.5K 0.14% 141
2015
Q3 		$147K Sell
133
-15
-10% -$17.4K 0.07% 183
2015
Q2 		$149K Buy
148
+25
+20% +$27K 0.06% 223
2015
Q1 		$125K Buy
123
+85
+224% +$281K 0.05% 204
2014
Q4 		$125K Buy
+38
New +$117K 0.05% 233

Other funds holding NBSE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GBA
Garrison Bradford & Associates New York $88.4M AUM 15.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Cutter & Co Brokerage's NBSE Position: Q1 2018 in Review

Cutter & Co Brokerage sold out of NeuBase Therapeutics, Inc. Common Stock (NBSE) in Q1 2018, closing a stake of 100 shares — an estimated $74K sold.

Cutter & Co Brokerage first reported a position in NBSE in Q4 2014 and held it in 13 quarters. The position peaked at $292K in Q4 2015. 35 funds tracked by Wall St. Rank hold NBSE as of Q1 2018.

  • Cutter & Co Brokerage reported no remaining NeuBase Therapeutics, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Cutter & Co Brokerage sold 100 NeuBase Therapeutics, Inc. Common Stock shares in Q1 2018, an estimated $74K.
  • Cutter & Co Brokerage first reported a position in NeuBase Therapeutics, Inc. Common Stock in Q4 2014 and held it in 13 quarters.
  • Cutter & Co Brokerage's NeuBase Therapeutics, Inc. Common Stock position peaked at $292K in Q4 2015.
  • 35 funds tracked by Wall St. Rank held NeuBase Therapeutics, Inc. Common Stock as of Q1 2018.

Based on Cutter & Co Brokerage's 13F filing for Q1 2018, filed 11 May 2018.